Activation of prostaglandin e receptor 4 triggers secretion of gut hormone peptides GLP-1, GLP-2, and PYY

Endocrinology

Volumn 154, Issue 1, 2013, Pages 45-53

  Coskun, Tamer ^a   O'Farrell, Libbey S ^a   Syed, Samreen K ^a   Briere, Daniel A ^a   Beavers, Lisa S ^a   DuBois, Susan L ^a   Michael, Mervyn D ^a   Franciskovich, Jeffry B ^a   Barrett, David G ^a   Efanov, Alexander M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; MESSENGER RNA; PEPTIDE YY; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E1; PROSTAGLANDIN E2; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DOWN REGULATION; HORMONE RELEASE; IMPEDANCE; L CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ANIMALS; CELLS, CULTURED; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE 2; INTESTINES; MICE; PEPTIDE YY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; THIOPHENES; TRIAZOLES;

EID: 84871673456     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1446     Document Type: Article

References (37)

1. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP 2002 Prostaglandins as modulators of immunity. Trends Immunol 23:144-150 (Pubitemid 34178297)
2. Legler DF, Bruckner M, Uetz-von Allmen E, Krause P 2010 Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int J Biochem Cell Biol 42:198-201
3. Narumiya S, Sugimoto Y, Ushikubi F 1999 Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193-1226 (Pubitemid 29473315)
4. Sugimoto Y, Narumiya S 2007 Prostaglandin E receptors. J Biol Chem 282:11613-11617 (Pubitemid 47100657)
5. Aly A, Green K, Johansson C 1987 Prostaglandin synthesis in the human gastrointestinal mucosa. Scand J Gastroenterol 127:35-38 (Pubitemid 17067082)
6. Wallace JL 2008 Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? Physiol Rev 88:1547-1565
7. Dey I, Lejeune M, Chadee K 2006 Prostaglandin E2 receptor distribution and function in the gastrointestinal tract. Br J Pharmacol 149:611-623 (Pubitemid 44748054)
8. Takeuchi K, Kato S, Amagase K 2010 Prostaglandin EP receptors involved in modulating gastrointestinal mucosal integrity. J Pharmacol Sci 114:248-261
9. Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, Segi E, Tsuboi K, Sugimoto Y, Kobayashi T, Miyachi Y, Ichikawa A, Narumiya S 2002 The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 109:883-893 (Pubitemid 34275109)
10. Drucker DJ 2007 The role of gut hormones in glucose homeostasis. J Clin Invest 117:24-32 (Pubitemid 46048446)
11. Holst JJ 2007 The physiology of glucagon-like peptide 1. Physiol Rev 87:1409-1439 (Pubitemid 350041474)
12. Drucker DJ, Jin T, Asa SL, Young TA, Brubaker PL 1994 Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Mol Endocrinol 8:1646-1655
13. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM 2008 Glucose sensing in L cells: a primary cell study. Cell Metab 8:532-539
14. Tolhurst G, Reimann F, Gribble FM 2009 Nutritional regulation of glucagon-like peptide-1 secretion. J Physiol 587:27-32
15. Dubé PE, Brubaker PL 2004 Nutrient, neural and endocrine control of glucagon-like peptide secretion. Horm Metab Res 36:755-760 (Pubitemid 40115895)
16. Chang CH, Chey WY, Sun Q, Leiter A, Chang TM 1994 Characterization of the release of cholecystokinin from a murine neuroendocrine tumor cell line, STC-1. Biochim Biophys Acta 1221:339- 347
17. Reimann F, Tolhurst G, Gribble FM 2012 G-protein-coupled receptors in intestinal chemosensation. Cell Metab 15:421-431
18. Smith RL, Lee T, Gould NP, Cragoe Jr EJ 1977 Prostaglandin isosteres. 1. (8-aza-, 8,10-diaza-, and 8-aza-11-thia)-9-oxoprostanoic acids and their derivatives. J Med Chem 20:1292-1299 (Pubitemid 8176896)
19. Billot X, Chateauneuf A, Chauret N, Denis D, Greig G, Mathieu MC, Metters KM, Slipetz DM, Young RN 2003 Discovery of a potent and selective agonist of the prostaglandin EP4 receptor. Bioorg Med Chem Lett 13:1129-1132 (Pubitemid 36331815)
20. Machwate M, Harada S, Leu CT, Seedor G, Labelle M, Gallant M, Hutchins S, Lachance N, Sawyer N, Slipetz D, Metters KM, Rodan SB, Young R, Rodan GA 2001 Prostaglandin receptor EP4 mediates the bone anabolic effects of PGE2. Mol Pharmacol 60:36-41 (Pubitemid 32595231)
21. Verdonk E, Johnson K, McGuinness R, Leung G, Chen YW, Tang HR, Michelotti JM, Liu VF 2006 Cellular dielectric spectroscopy: a label-free comprehensive platform for functional evaluation of endogenous receptors. Assay Drug Dev Technol 4:609-619 (Pubitemid 46017404)
22. Drucker DJ, Brubaker PL 1989 Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine. Proc Natl Acad Sci USA 86:3953-3957 (Pubitemid 19154723)
23. D'Alessio D, Lu W, Sun W, Zheng S, Yang Q, Seeley R, Woods SC, Tso P 2007 Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system. Am J Physiol 293:R2163-R2169 (Pubitemid 350224007)
24. Estall JL, Drucker DJ 2006 Glucagon-like peptide-2. Annu Rev Nutr 26:391-411
25. Simpson AK, Ward PS, Wong KY, Collord GJ, Habib AM, Reimann F, Gribble FM 2007 Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line. Diabetologia 50:2181-2189 (Pubitemid 47373843)
26. Henquin JC 2009 Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia 52:739-751
27. Islam D, Zhang N, Wang P, Li H, Brubaker PL, Gaisano HY, Wang Q, Jin T 2009 Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic β- and intestinal L-cell lines. Am J Physiol 296:E174-E181
28. Curtis-Prior PB, Jenner M, Smethurst M, Woodward JW 1979 Plasma prostaglandin levels in fed and starved lean, normal and obese women. Experientia 35:911-912 (Pubitemid 9225399)
29. Martínez ME, Heddens D, Earnest DL, Bogert CL, Roe D, Einspahr J, Marshall JR, Alberts DS 1999 Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa. J Natl Cancer Inst 91:950-953 (Pubitemid 29272521)
30. Karagiannides I, Pothoulakis C 2007 Obesity, innate immunity and gut inflammation. Curr Opin Gastroenterol 23:661-666 (Pubitemid 47508797)
31. Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C, Hardt PD 2010 Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18:190-195
32. Willemsen LE, Koetsier MA, van Deventer SJ, van Tol EA 2003 Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E1 and E2 production by intestinal myofibroblasts. Gut 52:1442-1447 (Pubitemid 37176724)
33. Cox MA, Jackson J, Stanton M, Rojas-Triana A, Bober L, Laverty M, Yang X, Zhu F, Liu J, Wang S, Monsma F, Vassileva G, Maguire M, Gustafson E, Bayne M, Chou CC, Lundell D, Jenh CH 2009 Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E2 and cytokines. World J Gastroenterol 15:5549-5557
34. Ohinata K, Suetsugu K, Fujiwara Y, Yoshikawa M 2006 Activation of prostaglandin E receptor EP4 subtype suppresses food intake in mice. Prostaglandins Other Lipid Mediat 81:31-66
35. Jiang GL, Nieves A, Im WB, Old DW, Dinh DT, Wheeler L 2007 The prevention of colitis by E prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration. J Pharmacol Exp Ther 320:22-28 (Pubitemid 46025715)
36. Cameron HL, Perdue MH 2005 Stress impairs murine intestinal barrier function: improvement by glucagon-like peptide-2. J Pharmacol Exp Ther 314:214-220 (Pubitemid 41058258)
37. Hornby PJ, Moore BA 2011 The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease. Expert Opin Ther Targets 15:637-646